Last reviewed · How we verify
Levothyroxine supplementation
At a glance
| Generic name | Levothyroxine supplementation |
|---|---|
| Also known as | T4 supplementation |
| Sponsor | Université de Sherbrooke |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients (NA)
- Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery (PHASE3)
- Levothyroxine Supplementation for Heart Transplant Recipients (PHASE1)
- Correlation Between Levothyroxine and Blood Th17/Treg in Pregnant Women With Normal-high TSH and Positive TPOAb
- Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass (PHASE3)
- Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism. (PHASE4)
- Effects of Krill Oil on Intestinal Integrity Markers in Elite Rowers. (NA)
- Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levothyroxine supplementation CI brief — competitive landscape report
- Levothyroxine supplementation updates RSS · CI watch RSS
- Université de Sherbrooke portfolio CI